A detailed history of Townsquare Capital LLC transactions in Repligen Corp stock. As of the latest transaction made, Townsquare Capital LLC holds 14,106 shares of RGEN stock, worth $1.76 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
14,106
Previous 13,436 4.99%
Holding current value
$1.76 Million
Previous $1.69 Million 23.98%
% of portfolio
0.03%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.79 - $167.35 $80,259 - $112,124
670 Added 4.99%
14,106 $2.1 Million
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $270,840 - $412,918
2,257 Added 20.19%
13,436 $1.69 Million
Q1 2024

May 15, 2024

BUY
$170.78 - $208.42 $108,786 - $132,763
637 Added 6.04%
11,179 $2.06 Million
Q4 2023

Feb 15, 2024

BUY
$114.17 - $185.35 $123,075 - $199,807
1,078 Added 11.39%
10,542 $1.9 Million
Q3 2023

Nov 15, 2023

BUY
$138.78 - $176.51 $140,584 - $178,804
1,013 Added 11.99%
9,464 $1.5 Million
Q2 2023

Nov 13, 2023

SELL
$138.42 - $180.31 $33,082 - $43,094
-239 Reduced 2.75%
8,451 $1.2 Million
Q1 2023

May 11, 2023

BUY
$154.26 - $198.1 $146,238 - $187,798
948 Added 12.24%
8,690 $1.46 Million
Q4 2022

Feb 13, 2023

BUY
$162.42 - $220.56 $318,505 - $432,518
1,961 Added 33.92%
7,742 $1.31 Million
Q3 2022

Nov 10, 2022

SELL
$160.42 - $256.21 $12,673 - $20,240
-79 Reduced 1.35%
5,781 $1.08 Million
Q2 2022

Aug 08, 2022

BUY
$140.68 - $188.02 $110,996 - $148,347
789 Added 15.56%
5,860 $952,000
Q1 2022

Apr 28, 2022

BUY
$161.19 - $257.96 $357,035 - $571,381
2,215 Added 77.56%
5,071 $954,000
Q4 2021

Feb 11, 2022

SELL
$247.59 - $304.47 $55,707 - $68,505
-225 Reduced 7.3%
2,856 $756,000
Q3 2021

Nov 15, 2021

BUY
$194.77 - $324.21 $94,268 - $156,917
484 Added 18.64%
3,081 $891,000
Q2 2021

Aug 16, 2021

BUY
$165.87 - $220.95 $229,066 - $305,131
1,381 Added 113.57%
2,597 $530,000
Q1 2021

May 17, 2021

BUY
$180.37 - $226.26 $219,329 - $275,132
1,216 New
1,216 $236,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Townsquare Capital LLC Portfolio

Follow Townsquare Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Townsquare Capital LLC with notifications on news.